Glenmede Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.67M Buy
+77,140
New +$1.67M 0.01% 598